Literature DB >> 8481516

Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding.

M H Lee1, E Vosburgh, K Anderson, J McDonagh.   

Abstract

A 63-year-old man was evaluated for a lifelong history of bleeding commencing with frequent epistaxis as a child; all previous routine coagulation parameters were within the normal range. The patient's hemorrhagic disorder is characterized predominantly by delayed bleeding at surgical sites. In the resting state, there was no clinical or laboratory evidence of excessive fibrin(ogen)olysis. Bleeding was not caused by disseminated intravascular coagulation, factor XIII deficiency, alpha 2-antiplasmin deficiency, or dysfibrinogenemia. It was found that the patient was deficient in plasma PAI-1 antigen and activity but with approximately half normal antigen and normal activity of platelet PAI-1. The low concentration of plasma PAI-1 was insufficient to neutralize circulating t-PA, resulting in high t-PA activity with normal antigen and causing the hyperfibrinolytic activity observed. Studies on seven family members of the proband indicated autosomal inheritance of plasma PAI-1 deficiency. Studies on this patient emphasize a clear correlation between decreased plasma PAI-1 activity and hyperfibrinolytic bleeding and also emphasize the unique role of plasma PAI-1 in the balance between the coagulation and fibrinolytic mechanisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481516

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Bleeding diathesis in a child with normal screening tests: think about fibrinolysis.

Authors:  Vanessa Largent; Véronique Deneys; Bénédicte Brichard; Christophe Chantrain; Christiane Vermylen
Journal:  Eur J Pediatr       Date:  2005-06-07       Impact factor: 3.183

2.  Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-alpha.

Authors:  C Fearns; D J Loskutoff
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  Translational and transcriptional responses in human primary hepatocytes under hypoxia.

Authors:  Gaya K Hettiarachchi; Upendra K Katneni; Ryan C Hunt; Jacob M Kames; John C Athey; Haim Bar; Zuben E Sauna; Joseph R McGill; Juan C Ibla; Chava Kimchi-Sarfaty
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

4.  Lower-extremity functional electrical stimulation decreases platelet aggregation and blood coagulation in persons with chronic spinal cord injury: a pilot study.

Authors:  Nighat N Kahn; Susan P Feldman; William A Bauman
Journal:  J Spinal Cord Med       Date:  2010       Impact factor: 1.985

Review 5.  A slice of PAI.

Authors:  D J Loskutoff
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 6.  PAI-1 in tissue fibrosis.

Authors:  Asish K Ghosh; Douglas E Vaughan
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

7.  Genomics: risk and outcomes in cardiac surgery.

Authors:  Tjorvi E Perry; Jochen D Muehlschlegel; Simon C Body
Journal:  Anesthesiol Clin       Date:  2008-09

8.  Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.

Authors:  P Carmeliet; J M Stassen; L Schoonjans; B Ream; J J van den Oord; M De Mol; R C Mulligan; D Collen
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.

Authors:  F Samad; K Yamamoto; D J Loskutoff
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 10.  Impact of genetic variation on perioperative bleeding.

Authors:  Jochen D Muehlschlegel; Simon C Body
Journal:  Am J Hematol       Date:  2008-09       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.